On indocyanine green angiography , a significantly greater proportion of the low-fluence PDT group ( 16 eyes ; 88.9 % ) showed a marked reduction in choroidal hyperpermeability after primary treatment than that of the ranibizumab group ( 0 eyes ; P < 0.001 ) .